Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications
Extension without change of a currently approved collection
No
Regular
06/16/2021
Requested
Previously Approved
36 Months From Approved
07/31/2021
28,174
11,589
14,934
9,293
0
0
The Food and Drug Administration (FDA) is requesting approval of a new generic for collecting information through the use of qualitative methods for studies about tobacco products. FDA will employ qualitative research, including individual in-depth interviews (IDIs), small group discussions, and focus groups to explore knowledge and perceptions about tobacco-related topics with specific target audiences. FDA will only submit an individual generic collection for approval under this generic clearance if the individual collection meets the outlined conditions.
US Code:
21 USC 355
Name of Law: Family Smoking Prevention And Tobacco Control Act
US Code:
21 USC 393
Name of Law: FFDCA
Our estimated burden for the information collection reflects an overall increase of 5,641 hours and a corresponding increase of 16,585 responses The burden is now estimated to be 14,934 hours.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.